HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 148 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $302 | -59.1% | 9,246 | -31.0% | 0.03% | -62.2% |
| Q4 2022 | $738 | -99.8% | 13,400 | +76.1% | 0.07% | +76.2% |
| Q2 2022 | $371,000 | -20.7% | 7,610 | -21.0% | 0.04% | -23.6% |
| Q1 2022 | $468,000 | +23.5% | 9,630 | +8.2% | 0.06% | +31.0% |
| Q4 2021 | $379,000 | +20.7% | 8,900 | +8.5% | 0.04% | +10.5% |
| Q3 2021 | $314,000 | – | 8,200 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
| venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
| Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
| Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
| ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
| TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
| MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
| O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |